Cancer Research UK makes key appointments to its governing council
Cancer Research UK announced a number of appointments to its Council of Trustees today (Tuesday 18 September).
David Newbigging, the current Chairman, has been appointed for a further three year term from the expiry of his current term on 31 October 2007.
Dr Melanie Lee, a Trustee and Chairman of the Charity's technology transfer subsidiary Cancer Research Technology (CRT), has been appointed Deputy Chairman of the Council in succession to Professor Sir David Carter who retired at the Annual General Meeting on 13 September 2007.
Dame Bridget Ogilvie, a Trustee and former Director of the Wellcome Trust has been appointed Chairman of the Charity's Council Research Strategy Group, also succeeding Professor Sir David Carter.
Sir Kenneth Calman, Chancellor of the University of Glasgow and former Vice Chancellor of the University of Durham, was appointed to the Council of Trustees at the Annual General Meeting on 13 September 2007. Sir Kenneth is a renowned cancer expert and is former Chief Medical Officer at the Department of Health. He co-authored the Calman-Hine Report which led to an overhaul of cancer services in the UK.
David Newbigging said: "I'm honoured to have been appointed Chairman for a second three-year term. I'm also delighted that Dr Melanie Lee and Dame Bridget Ogilvie have been respectively appointed Deputy Chairman of Council and Chair of our Cancer Research Strategy Group in succession to Sir David Carter. They bring wide experience of scientific and medical research. We are also fortunate that Sir Kenneth Calman has agreed to join our Council and its Research Strategy Group.
"I should like to pay tribute to the immense contribution which Sir David Carter has made to Cancer Research UK. He was a Founding Trustee and we have been very fortunate to have had him on the Council during our formative years."
For more information contact the Cancer Research UK press office on 020 7061 8300.
Notes to Editor
David Newbigging OBE
David Newbigging was appointed to Council in 2001. Born in 1934 Mr Newbigging was appointed Chairman in November 2004, having been Deputy Chairman since March 2002. He was Chairman of Friends Provident plc until May 2005 and Chairman of Talbot Holdings Limited until July 2007. He is a Director of Cancer Research Technology. He is also Chairman of Synesis Life Ltd. He was a director of Merrill Lynch & Co Inc in New York from 1996 to April 2007, and was a director of PACCAR Inc in Bellevue, Washington from 1999 to 2006. His early career was spent in Asia where he worked for 30 years for the Jardine, Matheson Group of which he was Chairman and Chief Executive for nine years before relocating to the UK in 1984. In Hong Kong he was a member of the Executive and Legislative Councils and Chairman or Director of several publicly listed companies. His former appointments in the UK include Chairman of Rentokil Group plc, Equitas Holdings Limited and Thistle Hotels plc. His non-business interests include being a Trustee of National Crimebeat. He is a former Chairman of the Wiltshire Community Foundation. He was High Sheriff of Wiltshire in 2003/04 and was also Chairman of the Council of the Mission to Seafarers from 1993 to 2006.
Dr Melanie Lee
Dr Melanie Lee was appointed to Council in 2004. Born in 1958, Dr Lee studied as a postdoctoral scientist with the Cancer Research Campaign and the Imperial Cancer Research Fund. She is currently Executive Vice-President Research and Development of UCB Pharma, a leading Global based Biopharmaceutical company. Dr Lee joined the Board of Imperial Cancer Research Technology Ltd (ICRT) in 2001 and, following the merger of ICRF and CRC, played a key role in the strategic planning of the business model for Cancer Research UK's technology transfer company, Cancer Research Technology Limited (CRT), and became its Chairman in 2003. She sits on the Parliamentary and Scientific Committee, is Chairman of the Applied Genomics LINK Scheme Programme Management Committee, is a member of the Biochemistry Society and the Genetics Society, and was elected a Fellow of the Academy of Sciences in 2003. Dr Lee received an Honorary Postdoctoral Degree from the University of York in 2004 and is a William Pitt Fellow of Pembroke College, Cambridge.
Dame Bridget Ogilvie AC DBE
Dame Bridget Ogilvie was appointed to Council in 2001. Born in 1938 Dame Bridget obtained her doctoral degrees from the University of Cambridge for research in parasitology. Before joining the Wellcome Trust in 1979, she was a member of the scientific staff of the National Institute for Medical Research. She was Director of the Wellcome Trust between 1991 and 1998. She is currently based at University College London as a Visiting Professor. Dame Bridget occupies herself with a variety of non-executive roles.
Sir Kenneth Calman, FRSE, PhD, BSc, FRCP, FRCS(Ed), FRCGP
Sir Kenneth Calman was appointed to Council in 2007. Born in 1941, Sir Kenneth began his medical training at the University of Glasgow in 1959, and took a BSc in Biochemistry before graduating in medicine in 1967. After working on aspects of dermatology for his PhD, he completed his hospital training, and then spent two years as the Medical Research Council Clinical Research Fellow at the Chester Beatty Research Institute in London. He returned to the University of Glasgow in 1974 as Professor of Oncology and held a series of senior posts, including Dean of Postgraduate Medicine and Professor of Postgraduate Medical Education. He was appointed Chancellor of the University of Glasgow in April 2007, having just completed almost nine years as Vice Chancellor at the University of Durham. While in Durham he was a member of the Regional Committee of the CBI and of the North East Chamber of Commerce. Before taking up his appointment at the University of Durham he was Chief Medical Officer at the Scottish Home and Health Department from 1989 and the Chief Medical Officer for England (1991-98). Sir Kenneth also served for many years as a prominent clinical professor and he is the author of many books on the care and treatment of cancer and on medical education. His most recent book is on the history of medical education. He is currently a member of the Nuffield Council on Bioethics, and President of the Institute of Medical Ethics. He chairs the NHS Genetics Education Group and is a member of the Scottish Science Advisory Committee. Sir Kenneth has served as Chairman of the Executive Board of the World Health Organisation and the European Environment and Health Committee. He is a Fellow of several academic and professional bodies including the Royal College of Physicians, the Royal College of Surgeons and the Royal Society of Edinburgh. In 1996 he became a Knight Commander of the Order of the Bath.
Cancer Research UK
Together with its partners and supporters, Cancer Research UK's vision is to beat cancer.
- Cancer Research UK carries out world-class research to improve understanding of the disease and find out how to prevent, diagnose and treat different kinds of cancer.
- Cancer Research UK ensures that its findings are used to improve the lives of all cancer patients.
- Cancer Research UK helps people to understand cancer, the progress that is being made and the choices each person can make.
- Cancer Research UK works in partnership with others to achieve the greatest impact in the global fight against cancer.
For further information about Cancer Research UK's work or to find out how to support the charity, please call 020 7009 8820 or visit our homepage.